4579.T
RaQualia Pharma Inc.

Healthcare · Biotechnology · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

46.90M USD

Market Cap

101.20M USD

Margin of Safety

-115.8%

Intrinsic / Market Ratio

0.46×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

43.87M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

48.41M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

48.41M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

46.90M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

46.90M USD

from the sum above

Market Cap

101.20M USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.46×

the ratio the screener ranks by; Margin of Safety -115.8% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 43.87M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)9.24M USD
+②Net Cash Today12.43M USD
+③Growth Value22.20M USD
=Value43.87M USD

EPV of the Operations (NOPAT over WACC)

9.24M USD

Net cash today

+12.43M USD

Growth Value

+22.20M USD

Value

43.87M USD

①EPV (earnings power value)

9.24M USD

②Net Cash Today

12.43M USD

③Growth Value

22.20M USD

Market value

Market Cap101.20M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-130.7%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 48.41M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.

The projection was not made (a profit at or below zero in the latest three years), so the value is the book value today, 48.41M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFE

Not in the value

②Equity at Year 15, Today

Not in the value

Market value

Market Cap101.20M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-109.0%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 48.41M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (a change in working capital above half the operating profit in the latest three years), so the value is the book value today, 48.41M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap101.20M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-109.0%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 8.75%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.91×Market Risk Premium 6.00%= 9.95%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 1.05M USDPretax Income 2.80M USD= 37.64%

The tax the interest saves.

Interest Expense =EBIT 3.18M USD−Pretax Income 2.80M USD= 377.94K USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 377.94K USDTotal Debt 16.60M USD×(1 − Tax Rate for WACC 37.64%)= 1.42%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 16.60M USDMarket Cap + Total Debt 101.20M USD + 16.60M USD= 14.10%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 85.90%×Cost of Equity 9.95%+Debt Weight 14.10%×Cost of Debt 1.42%= 8.75%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 68.04M USD − Total Liabilities 19.63M USD = Book Value Today 48.41M USD

Total Debt 16.60M USD − Cash and Short-Term Investments 29.03M USD = Net Debt Today -12.43M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 120.4%at most 5%does not pass26,031,232 / 21,623,230
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets-5.9%at least -10.0%passes(-2.27M USD − 1.75M USD) ÷ 68.04M USD
Price to bookMarket Cap ÷ Book Value Today2.09×at most 3×passes101.20M USD ÷ 48.41M USD
Operating marginOperating Income ÷ Revenue12.2%above 10.0%passes3.10M USD ÷ 25.47M USD
Revenue growthRevenue ÷ Revenue a Year Before − 128.5%above 10.0%passes25.47M USD / 19.81M USD
Net cash(Cash − Total Debt) ÷ Market Cap11.5%above -30%passes(28.28M USD − 16.60M USD) ÷ 101.20M USD
Operating efficiencyOperating Income ÷ Gross Profit14.8%above 25.0%does not pass3.10M USD ÷ 20.91M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

609.61 JPY

Enterprise value

13.85B JPY

the provider's own figure

EV / EBITDA

17.07×

Price / book

2.02×

the provider's book

Price / earnings

69.76×

Return on equity

2.3%

the provider's figure, not this page's

Profit margin

4.1%

Revenue growth

14.6%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

21.98M13.46M19.81M25.47M

Gross profit

20.23M11.72M15.82M20.91M

Operating income

6.52M-2.39M-1.36M3.10M

EBITDA

operating income before depreciation and amortisation

7.57M-791.32K551.75K6.30M

Pretax income

6.41M-2.08M-2.28M2.80M

Net income

5.45M-2.29M-3.16M1.75M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

5.77M-2.18M-3.07M1.64M

R&D

9.40M9.71M10.86M10.24M
Balance sheet, year end

Total assets

47.13M48.64M61.56M67.29M

Total liabilities

5.73M5.32M26.05M23.15M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

41.40M43.32M35.52M44.13M

Total debt

1.67M2.60M22.01M18.57M

Cash and equivalents

27.68M26.29M21.30M20.74M

Net PP&E

fixed assets after depreciation

2.94M4.06M3.37M2.79M

Working capital

current assets less current liabilities

32.60M32.33M21.37M28.21M
Cash flow

Operating cash flow

11.15M-5.09M1.15M-2.27M

Capital expenditure

paid out, so below zero

-240.28K-1.57M-738.97K-477.85K

Depreciation and amortisation

1.11M1.24M2.56M3.12M

Free cash flow

operating cash flow plus capital expenditure

10.91M-6.66M414.73K-2.75M